| Setting
The Danish health care system is publicly funded, and all citizens have free access to diagnostics and treatment. More than 98% of citizens in Denmark are listed with a specific general practice, and GPs serve as gatekeepers for specialised services at hospitals. The Danish CPPs are standardised guidelines for diagnosing and treatment of 34 types of cancers including maximum time frames for each phase from referral to treatment. GPs can urgently refer patients to a CPP, if there is a reasonable suspicion of cancer (Probst et al., 2012) .
| Study population
We used data from the sampling frame of the 2010 Danish Cancer in Primary Care cohort (Jensen, Torring, Larsen, et al., 2014) . The National Patient Registry was used for identifying patients eligible for inclusion, which allowed a prospective inclusion of new cases and exclusion of patients with cancer recurrence. The study population (n = 7,562) consisted of all persons aged 18 years or older who were registered with a first time cancer diagnosis (ICD-10: C00.0-C99.9, except C44 [non-melanoma skin cancer]) in the National Patient Registry (Andersen, Madsen, Jorgensen, Mellemkjoer, & Olsen, 1999) between 1 May 2010 and 31 August 2010, and resident in Denmark (Larsen, Jensen, Hansen, Olesen, & Vedsted, 2014) .
After exclusions due to data protection, death before mail-out, and unknown address the remaining patients received a questionnaire.
| Data collection

| Patient survey
The patient-reported data derives from a nationwide questionnaire survey of cancer patients' experiences with diagnostics and treatment of cancer in Denmark. We mailed a questionnaire, including a prepaid envelope, to each patient in the study population that was alive at the time and who did not have a standing rejection to be contacted by researchers. The questionnaire was distributed twice (21 September and 25 October 2010) to ensure that patients received the questionnaire as close to the time of diagnosis as possible. Due to registration delay in the National Patient Registry, the patients received the questionnaire approx.
three to four months after the cancer diagnosis. Non-responders received a reminder including a new questionnaire approx. three weeks after receiving the first questionnaire. The questionnaire was developed to give a broad insight into the needs of cancer patients and their experiences with the health care system during diagnostics and treatment. The questionnaire was critically assessed by a professional advisory panel and further tested by cognitive interviews with 13 patients, who differed with regard to age, gender and diseases .
A total of 4,010 (53%) (64% for questionnaires sent [i.e., percentage of responding patients who were contacted, alive and not flagged in the Civil Registration System with a standing rejection to be contacted for research purposes]) eligible patients returned a questionnaire. Responding patients were more likely to be female, between 45 and 74 years, diagnosed with breast cancer or malignant melanoma. Furthermore, they were more likely to have higher one-year survival rates, more localised tumours and a higher educational level and disposable household income (Jensen, Torring, Larsen, et al., 2014) .
| GP survey
For each patient included, a questionnaire was sent to the patient's GP in late autumn 2010. The questionnaire included previously tested questions about that is milestone dates, referral route and quality deviations (QDs) and GPs completed the questionnaire based on information from the electronic medical records (Jensen, Torring, Larsen, et al., 2014) . After approximately four weeks, a reminder including a new questionnaire was sent to non-responders.
GP questionnaires were returned in 5,581 cases (73.8%). Patients from responding GPs were more likely to be female, younger, have breast cancer and to have higher disposable household income (Jensen, Torring, Larsen, et al., 2014) .
| Variables
The primary variables of interest were urgent referral to CPP by the GP and the patients' experience of the pre-diagnosis cancer care.
Information on whether or not the patient was urgently referred to a CPP was based on the GP-reported information on referral route (Jensen, Torring, Larsen, et al., 2014) . Information on patient-reported experiences was based on the patient questionnaire and included one item about the overall experience of the pre-diagnosis phase (Q1), four items related to the diagnostic phase in general practice (Q2-5) and three variables relating to the diagnostic phase in hospital (Q6-8) (Box 1).
Possible confounding variables were selected a priori including gender, age, cancer type, comorbidity, educational level, disposable household income, patient-reported QDs and diagnostic interval.
Patients' gender and age were derived from the Danish Civil Registration number. Cancer type was retrieved from the National Patient Registry and verified by data from the Danish Cancer Registry.
The diagnostic interval was defined as the time from patients' first presentation of symptoms to the GP (GP reported) until the date of diagnosis (from the Danish Cancer Registry) (Jensen, Torring, Larsen, et al., 2014) .
Patient-reported QDs were categorised as present when the patient reported the worst category in any question regarding: information given, communication with health care professionals, missed test (results), adverse events in primary care, waiting time and insufficient collaboration between GP and secondary care (i.e., medical specialists) .
Box 1 Wording and categorisation of items on cancer patients' experiences during pre-diagnosis cancer care TA B L E 1 Characteristics of the included 2,256 patients by referral route and total 
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Comorbidity was categorised according to Charlson Comorbidity
Index (Charlson, Pompei, Ales, & MacKenzie, 1987) based on data derived from the Danish National Patient Register (excluding the cancer in question) (Jensen, Torring, Larsen, et al., 2014) .
Data from Statistics Denmark were used to calculate disposable household income (OECD equivalent) and educational level (in accordance with the International Standard Classification of Education) (Jensen, Torring, Larsen, et al., 2014) .
| Ethics
The 
| Data analyses
Complete case analyses were done. Differences between referral groups were compared using Pearson chi-square test test.
We estimated the patients' likelihood to report the most positive experience in relation to whether the patient was referred to a CPP or not by calculating the prevalence ratios (PRs) using Poisson regression as the outcome was frequent (Barros & Hirakata, 2003) . The analyses were adjusted in five specific steps: 1st step was adjusted for casemix: sex, age and diagnoses, 2nd step equalled step 1 + comorbidity, 3rd step equalled step 2 + disposable household income and education, 4th step equalled step 3 + QDs, 5th step equalled step 3 + diagnostic interval. Furthermore, all models were adjusted for patient clusters at GP level. Statistical significance was set at 0.05 or less, and 95% confidence intervals are shown when appropriate. Analyses were done using Stata® v. 14 (StataCorp LP, College Station, TX, USA).
| RE SULTS
A total of 2,256 patients with returned questionnaires from both patient and GP were included in the analyses. The characteristics are shown in Table 1 .
Of these cases, 892 (39.5%) were referred to a CPP by the GP.
Patients referred to a CPP were more likely to be women, have breast cancer, not to have experienced QDs and to have shorter diagnostic intervals. Non-CPP patients were more likely to have other cancers. No other differences were observed between CPP and non-CPP patients (Table 1) .
Overall, more CPP referred patients than non-CPP referred patients rated the pre-diagnosis pathway as particularly good (Q1) (62.9% vs. 49.4%). More CPP referred than non-CPP referred patients reported the most positive experience on all eight questions (Table 2 ). The largest differences were observed for items from the "contact with GP" domain, where CPP referred patients reported more positive experiences with absolute differences from 11.4% to 15.3% (Table 2 ). Smaller differences were observed for items from the "contact with hospital" domain, with absolute differences ranging from 4.9% to 7.4% (Table 2 ).
For seven out of eight questions, being referred to a CPP statistically significantly increased the likelihood of having a positive experience of the diagnostic phase after adjustments for confounders (Table 3) . CPP referred patients were 21% more likely than non-CPP referred patients to report having a more positive overall experience of the pre-diagnosis phase (Q1) after adjustment for case-mix, comorbidity, disposable household income and educational level (PR = 1.21 [95% CI: 1.11-1.30]) (Table 3 ). This likelihood attenuated to 14% when adjusted for the presence of QDs (PR = 1.14 [95% CI:
1.06-1.23]), and to 11% when adjusted for the length of the diagnostic interval (PR = 1.11 [95% CI: 1.02-1.20]) (Table 3 ).
Similar patterns were seen for all questions. The smallest differences were observed for items related to the "contact to hospital" domain and the largest for items related to the "contact with GP" domain ( Table 3) . Table 4 (Table 4) .
| D ISCUSS I ON
This study shows that cancer patients referred to a CPP by their GP are more likely to report a positive experience of pre-diagnosis cancer care than patients not referred to a CPP by their GP. The study also shows that the differences between CPP and non-CPP patients' experiences were larger for items related to general practice than items related to the hospital. Finally, the study showed that comorbidity, disposable household income and educational level did not influence these results, whereas the presence of QDs and the length of diagnostic interval accounted for up to half of the differences in positive experiences between CPP and Non CPP referred patients.
| Strengths and limitations of the study
A major strength of this study is the large number of participating
GPs and patients together with the possibility to linkage of individual-level data to national registries. Furthermore, the study population is well-defined, including all cancer types regardless of initial symptom(s) due to the identification through the National Patient
Registry, where almost all Danish cancer patients are registered (Gjerstorff, 2011) . TA B L E 3 Likelihood for the CPP referred patients compared to the non-CPP referred patients to report the best possible experience with different categories of the pre-diagnosis cancer care; expressed as prevalence ratios (PRs) with 95% confidence intervals 
TA B L E 2 Distribution of patient responses by referral route and total
Non-CPP CPP
The survey included patients who had recently received a cancer diagnosis. However, due to delay in registration and post-sampling mortality there was a risk that patients with aggressive cancers were underrepresented in the final study sample, both due to death and morbidity.
It may be that patients with aggressive cancers have different symptom profiles and to a greater extent present alarm symptoms to the GP and therefore are more likely to be referred to a CPP (Jensen, Torring, Olesen, et al., 2014) . If these patients at the same time are less likely to report positive experiences due to the seriousness of their situation, we may have overestimated the effect of CPP on patient experience. However, the link between severity of disease and patient experience is unclear.
Although the effect has been shown to be relatively small , it was decided to send out the questionnaires in two rounds to ensure that the patients received the questionnaire as close to the time of diagnosis as possible-and thereby minimising the effect of potential survival bias.
Non-response, both among patients and GPs, might have produced a selection bias. It is well known that a number of socio-demographic characteristics such as age and education generally affect willingness to respond. Additionally, it might be that cancer patients with poor prognosis find themselves too ill to answer the questionnaire, and therefore response rates may vary between different cancer severity groups. In fact, responding patients in the survey were more likely to be diagnosed with cancers with higher survival rates (Jensen, Torring, Larsen, et al., 2014 ). Yet, we have no reason to suspect, that the willingness to participate depended on both the GPs choice of referral route and the patients experience. In fact, the proportion of CPP referred patients among respondents are similar to other studies (Jensen, Torring, et al., 2015; Jensen, Torring, Olesen, et al., 2014; Meechan et al., 2012) . All in all, the direction and amount of the bias observed will not change the conclusion of this study.
We believe that the results from our included population of cancer patients make the study results generalisable, although caution in interpreting the absolute differences is advised.
Data on referral route and patient experiences are dependent on the memory of the GPs and the patients,respectively, as the answers are given retrospectively. Patients filled in the questionnaire approximately 3-4 months after receiving a cancer diagnosis. Patient satisfaction tends to decrease over time (Bjertnaes, 2012; Jensen, Ammentorp, & Kofoed, 2010) , but as we do not expect time itself to affect experiences of CPP and non-CPP patients in different ways, this would lead us to underestimate the true differences between the referral routes. Recall bias cannot be ruled out for the GP answers. But, as the GPs were asked to use their electronic medical records to document whether the patient was CPP referred, we do not expect this bias to be differential.
| Comparison with the literature
To our knowledge, this is the first study with a specific focus on patients' overall experience with pre-diagnosis cancer care TA B L E 4 (Continued) according to whether or not they were urgently referred to a CPP by their GP. Our main finding that CPP referred patients reported more positive experiences with pre-diagnosis cancer care corresponds to earlier findings that integrated care (Foglino et al., 2016) and shorter delay (Mendonca et al., 2016) is associated with better patient experiences.
A study has shown that patients with cancers that are "hard-to-detect" more frequently changed GP around the time of diagnosis compared to other cancer patients (Grooss, Hjertholm, Carlsen, & Vedsted, 2016) . This may indicate dissatisfaction with timeliness and the diagnostic pathways, which is supported by the results of this survey.
A plausible explanation why CPP referred patients reported more positive experiences with pre-diagnosis cancer care seem to be that the clearly defined time frames in the CPPs, led to decreased diagnostic intervals (Jensen, Torring, et al., 2015) , which have resulted in higher patient-reported satisfaction with waiting times (Dahl et al., 2017) . Indeed, our findings support this, as the length of the diagnostic interval accounted for up to half of the differences observed, which may also explain the association between number of pre-diagnosis GP consultations and patient experience reported by Mendonca et al. (2016) .
Generally, the associations were stronger for the GP related items than for the hospital related items. This may indicate that the differences between CPP and non-CPP patients' experiences are diminished as the diagnostic pathway progress.
Interestingly, we found that one-third of the differences in patient experiences between referral routes could be explained by differences in reported QDs. Up to a third of all cancer patients experience at least one QD during the pre-diagnosis (Jensen, Nissen, & Vedsted, 2014; Jensen, Sperling, et al., 2015) . It has been shown that patients having experienced a QD during the primary diagnostic phase have longer diagnostic interval (Jensen, Nissen, et al., 2014) , as the main consequence of QDs is delay (Hickner et al., 2008) . Hence, we may suspect that part of the increased diagnostic interval (and worse experiences) seen among non-CPP patients can be explained by a delay caused by more QDs in this group.
We expected that patients with comorbidity would rate their pre-diagnosis cancer care more negative as it has been stated, that patients with comorbidity are less likely to be referred to CPP (Probst et al., 2012) , and hence are more prone to longer diagnostic intervals. In this study, comorbidity did not influence the association between referral route and patient experiences which may be because the patient experience is stronger related to how the patient is initially seen and referred by the GP. The same goes for different levels of education and disposable household income.
Younger patients were less likely to report positive experiences than older patients, which is in line with other studies (Crow et al., 2002; Sitzia & Wood, 1997) . However, the reason why younger patients report their experiences worse than older patients may be a result of different expectations rather than actual differences in received health care (Bjertnaes, Sjetne, & Iversen, 2012; Sitzia & Wood, 1997) .
It has been suggested that the CPPs have resulted in more standardised and less patient-centred cancer care and thereby challenged professional ethos (Obling, 2013) . Our results do not support this argument from a patient perspective, as CPP referred patients reported more positive experiences with pre-diagnosis cancer care both overall and in relation to the interaction with health care professionals.
This study shows that patients benefit from being referred to CPPs and at the same time emphasises a need to focus on how to handle patients with unspecific symptoms. The fact that at least half of the cancer patients present themselves with unspecific symptoms, and these patients have longer time to diagnosis (Jensen, Torring, Olesen, et al., 2014) stresses the need for supplementary approaches other than CPPs. The Danish three-legged diagnostic strategy being an example of such .
It is generally believed that standardised CPPs will enhance clinical quality, reduce waiting times and improve patient experience. 
